1. Home
  2. LTRN vs RAVE Comparison

LTRN vs RAVE Comparison

Compare LTRN & RAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRN
  • RAVE
  • Stock Information
  • Founded
  • LTRN 2013
  • RAVE 1958
  • Country
  • LTRN United States
  • RAVE United States
  • Employees
  • LTRN N/A
  • RAVE N/A
  • Industry
  • LTRN Biotechnology: Pharmaceutical Preparations
  • RAVE Restaurants
  • Sector
  • LTRN Health Care
  • RAVE Consumer Discretionary
  • Exchange
  • LTRN Nasdaq
  • RAVE Nasdaq
  • Market Cap
  • LTRN 46.7M
  • RAVE N/A
  • IPO Year
  • LTRN 2020
  • RAVE N/A
  • Fundamental
  • Price
  • LTRN $3.54
  • RAVE $2.75
  • Analyst Decision
  • LTRN Hold
  • RAVE
  • Analyst Count
  • LTRN 1
  • RAVE 0
  • Target Price
  • LTRN N/A
  • RAVE N/A
  • AVG Volume (30 Days)
  • LTRN 27.6K
  • RAVE 17.3K
  • Earning Date
  • LTRN 03-27-2025
  • RAVE 05-01-2025
  • Dividend Yield
  • LTRN N/A
  • RAVE N/A
  • EPS Growth
  • LTRN N/A
  • RAVE 37.66
  • EPS
  • LTRN N/A
  • RAVE 0.18
  • Revenue
  • LTRN N/A
  • RAVE $12,236,000.00
  • Revenue This Year
  • LTRN N/A
  • RAVE N/A
  • Revenue Next Year
  • LTRN N/A
  • RAVE N/A
  • P/E Ratio
  • LTRN N/A
  • RAVE $15.43
  • Revenue Growth
  • LTRN N/A
  • RAVE 3.25
  • 52 Week Low
  • LTRN $2.79
  • RAVE $1.70
  • 52 Week High
  • LTRN $9.96
  • RAVE $3.36
  • Technical
  • Relative Strength Index (RSI)
  • LTRN 39.55
  • RAVE 48.48
  • Support Level
  • LTRN $3.62
  • RAVE $2.60
  • Resistance Level
  • LTRN $4.00
  • RAVE $3.10
  • Average True Range (ATR)
  • LTRN 0.24
  • RAVE 0.15
  • MACD
  • LTRN -0.00
  • RAVE -0.02
  • Stochastic Oscillator
  • LTRN 22.93
  • RAVE 30.00

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

Share on Social Networks: